Apimeds Pharmaceuticals US, Inc.
Asset & Liabilities Breakdown
Asset Breakdown FY2025
Total Assets: $164.2M
Liabilities Breakdown FY2025
Total Liabilities: $10.8M
Asset Breakdown
Total Assets: $164.2M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $1.6M | 1.0% |
| Accounts Receivable | $0 | 0.0% |
| Inventory | $0 | 0.0% |
| Property, Plant & Equipment | $51.6K | 0.0% |
| Goodwill | $0 | 0.0% |
| Intangible Assets | $0 | 0.0% |
| Other Assets | $162.5M | 99.0% |
Liabilities Breakdown
Total Liabilities: $10.8M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $0 | 0.0% |
| Long-Term Debt | $0 | 0.0% |
| Other Liabilities | $10.8M | 100.0% |